ALFA Finder| Management target | Revenue FY30 |
|---|
| Revenue growth | 46% YoY in Q1 FY27 |
|---|---|
| Margins | EBITDA margin 12.6%; Specialty Chemicals at 26% |
| Demand visibility | Strong growth in specialty films and B2C segments |
| Management confidence | High regarding ROCE improvement and business scale-up |
Growth
Q1 FY27 Revenue grew 46% to ₹1,166 Cr; EBITDA increased 26% to ₹147 Cr; PAT rose 25% to ₹54 Cr.
Outlook
Targeting Net Debt/EBITDA below 2.0x within 12-18 months; FY30 target revenue for Specialty Chemicals at ₹400-500 Cr.
Risks
Higher raw-material prices post West Asia conflict caused an ₹85 Cr working-capital increase.
Last quarter's promises, checked
Delivered
- Guided double-digit topline growth → delivered 46% YoY (= BEAT)
- Guided EBITDA improvement from Q4 (₹130 Cr) → delivered ₹147 Cr (= BEAT)
- Guided specialty chemicals topline growth → delivered 34% YoY (= BEAT)
Partly delivered
- Guided Net Debt/EBITDA below 2.0x in 12-18 months → currently 2.4x (= PARTIAL)
Investor Presentation filed with BSE, NSE: COSMOFIRST. Summary written with AI assistance from the document.
Cosmo First Ltd: key numbers
- Share price
- ₹813.00
- Market cap
- ₹2,134 Cr
- Revenue (annual)
- ₹3,639 Cr
- Net profit (annual)
- ₹156.0 Cr
- P/E (TTM)
- 9.8×Sector 46.8×
- Promoter holding
- 40.78%+0.00% QoQ
- FII holding
- 3.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cosmo First Ltd
All →Cosmo First Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹1,388 Cr (+51% YoY) on 15% volume; EBITDA ₹177 Cr (+38%) includes ~₹18 Cr net one-offs, normalized +24%.
Cosmo First Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,388 Cr (+51% YoY), EBITDA ₹177 Cr (12.8% margin), PAT ₹99 Cr (+111%, tax-aided). Net debt/EBITDA down to 1.9x from 3.0x; specialty mix improving.
Cosmo First Results Update
Cosmo First released Q2 FY27 consolidated results via press release, showing EBITDA and PAT growth. Net debt was reduced while B2B and consumer businesses scaled up.
Cosmo First Q2 FY27 Results: Net Profit ₹98.6 Cr, Up 111.1% YoY
Cosmo First Ltd reported revenue from operations of ₹1,388 Cr (+51.0% YoY) and net profit of ₹98.6 Cr (+111.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹98.6 Cr · +111.1% YoY
Cosmo First Board Meeting Date
COSMO FIRST Limited will hold a board meeting on 03-Nov-2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window closes from 01-Oct-2026 until 48 hours after results are published.
Cosmo First Acquisition Worth ₹6.1 Cr
Cosmo First Limited is acquiring Prolife Speciality Vet Clinic LLP for a cash consideration of ₹6.10 Crore to expand its Petcare division, Zigly.
- Value
- ₹6.10 Cr